SIRUM
-84%
est. 2Y upside i
SIRUM is a “match.com” for unused medicine. We connect institutional…
Rank
#4109
Sector
Healthcare Services
Est. Liquidity
~5Y
Data Quality
Data: MediumThe equity opportunity at SIRUM is highly unconventional due to its non-profit social enterprise model, offering limited traditional financial upside for common stock or options.
Last updated: February 24, 2026
SIRUM significantly expands its national footprint and impact through new state partnerships and increased grant funding, potentially leading to the creation of a successful for-profit arm or a substantial increase in its mission-driven "value" recognized by its stakeholders.
SIRUM continues its vital work, maintaining its operational scale and impact with consistent grant support, but faces ongoing challenges in achieving significant growth or traditional equity appreciation due to its non-profit structure.
SIRUM struggles with sustained revenue decline, faces increased competition from emerging drug redistribution programs, or encounters significant regulatory setbacks, leading to a reduction in its operational capacity and a substantial decrease in any perceived "equity" value.
Preference Stack Risk
lowWith only $120K in reported equity-like funding and an assumed implied valuation of $25M, the investor take ratio is extremely low at 0.48%, indicating minimal liquidation preferences ahead of common shareholders.
Dilution Risk
moderateWhile traditional equity dilution from future VC rounds is unlikely, the non-profit's continued reliance on grants means ongoing funding needs, which could indirectly impact the perceived value or payout of phantom equity.
Secondary Liquidity
noneGiven SIRUM's non-profit status and lack of traditional equity investors, there is no active secondary market for its equity, and liquidity would be highly uncertain.
Other — 1 role
- Partnership Manager, Chicago (Contract Role) · Chicago, IL
Last updated: March 10, 2026
Community
Valuation Sentiment
Our model estimates -84% upside. What do you think?
Anonymous. Do not share material non-public information.
Community Discussion
Comments are reviewed before they appear publicly.
Loading comments...
Disclaimer: This analysis is AI-generated and does not constitute financial or career advice. Always conduct your own due diligence.